These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32961563)

  • 21. Liraglutide alleviates high-fat diet-induced kidney injury in mice by regulating the CaMKKβ/AMPK pathway.
    Xuan Y; Ding TT; Mao XL; Pang S; He R; Qin L; Yuan JZ
    Ren Fail; 2024 Dec; 46(1):2351473. PubMed ID: 38915241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-steatotic linagliptin pleiotropic effects encompasses suppression of de novo lipogenesis and ER stress in high-fat-fed mice.
    Santos FO; Correia BRO; Marinho TS; Barbosa-da-Silva S; Mandarim-de-Lacerda CA; Souza-Mello V
    Mol Cell Endocrinol; 2020 Jun; 509():110804. PubMed ID: 32259637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.
    Yang M; Yao X; Xia F; Xiang S; Tang W; Zhou B
    BMC Complement Med Ther; 2024 Jan; 24(1):36. PubMed ID: 38216941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
    Zhu W; Feng PP; He K; Li SW; Gong JP
    Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.
    Sharma S; Mells JE; Fu PP; Saxena NK; Anania FA
    PLoS One; 2011; 6(9):e25269. PubMed ID: 21957486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of liraglutide combined with vitamin D on non-alcoholic fatty liver induced by high fat in mice and its mechanism].
    Wang F; Zhang HF
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 May; 36(3):261-264. PubMed ID: 32981283
    [No Abstract]   [Full Text] [Related]  

  • 27. The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD.
    Patel Chavez C; Cusi K; Kadiyala S
    J Clin Endocrinol Metab; 2022 Jan; 107(1):29-38. PubMed ID: 34406410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.
    Gaspari T; Brdar M; Lee HW; Spizzo I; Hu Y; Widdop RE; Simpson RW; Dear AE
    Diab Vasc Dis Res; 2016 Jan; 13(1):56-68. PubMed ID: 26408644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice.
    Legry V; Van Rooyen DM; Lambert B; Sempoux C; Poekes L; Español-Suñer R; Molendi-Coste O; Horsmans Y; Farrell GC; Leclercq IA
    Clin Sci (Lond); 2014 Oct; 127(7):507-18. PubMed ID: 24766485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease.
    Khoo J; Hsiang JC; Taneja R; Koo SH; Soon GH; Kam CJ; Law NM; Ang TL
    Liver Int; 2019 May; 39(5):941-949. PubMed ID: 30721572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal obesity alters endoplasmic reticulum homeostasis in offspring pancreas.
    Soeda J; Mouralidarane A; Cordero P; Li J; Nguyen V; Carter R; Kapur SR; Pombo J; Poston L; Taylor PD; Vinciguerra M; Oben JA
    J Physiol Biochem; 2016 Jun; 72(2):281-91. PubMed ID: 26979740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression.
    Zhou D; Chen YW; Zhao ZH; Yang RX; Xin FZ; Liu XL; Pan Q; Zhou H; Fan JG
    Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30510243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
    Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity.
    Noyan-Ashraf MH; Shikatani EA; Schuiki I; Mukovozov I; Wu J; Li RK; Volchuk A; Robinson LA; Billia F; Drucker DJ; Husain M
    Circulation; 2013 Jan; 127(1):74-85. PubMed ID: 23186644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile.
    Larsen AT; Gydesen S; Sonne N; Karsdal MA; Henriksen K
    BMC Endocr Disord; 2021 Jan; 21(1):10. PubMed ID: 33413317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis.
    Perakakis N; Stefanakis K; Feigh M; Veidal SS; Mantzoros CS
    Liver Int; 2021 Aug; 41(8):1853-1866. PubMed ID: 33788377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Linolenic Acid-Enriched Cold-Pressed Perilla Oil Suppress High-Fat Diet-Induced Hepatic Steatosis through Amelioration of the ER Stress-Mediated Autophagy.
    Bae SJ; Kim JE; Choi HJ; Choi YJ; Lee SJ; Gong JE; Seo S; Yang SY; An BS; Lee HS; Kim DS; Lee CY; Hwang DY
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32521713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
    Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
    Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.